US FDA Mum On Whether Woodcock Would Stick Around Long-Term For Califf

Woodcock’s willingness to stay on at US FDA for more than a transitional period after Robert Califf’s expected confirmation as commissioner may depend on exactly the type of authority and tasks he’d be willing to delegate to her. Plus, some other agency personnel updates.

Janet Woodcock
Janet Woodcock addressed her future plans during a session at the recent Biopharma Congress. • Source: Screenshot

More from US FDA

More from Agency Leadership